Th1-like dominance in high-risk first-degree relatives of Type I diabetic patients

Diabetologia

Volumn 43, Issue 6, 2000, Pages 742-749

  Karlsson, M G E ^a   Lawesson, S Sederholm ^a   Ludvigsson, J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

ABBOS; BSA; GAD65; GADA; High risk relatives; IFN ; IL 4; Insulin; Th lymphocyte; Type I diabetes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; TH1 CELL;

EID: 0034089590     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051372     Document Type: Article

References (51)

1. 1. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353-360
2. 2. Castano L, Eisenbarth GS (1990) Type-I diabetes: A chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8: 647-679
3. 3. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7: 145-173
4. 4. Liblau RS, Singer SM, McDevitt HO (1995) Th1 and Th2 CD4 + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16: 34-38
5. 5. Song YH, Li Y, Maclaren NK (1996) The nature of autoantigens targeted in autoimmune endocrine diseases. Immunol Today 17: 232-238
6. 6. Baekkeskov S, Landin M, Kvist Kristensen J et al. (1987) Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926-934
7. 7. Baekkeskov S, Aanstoot H-J, Christgau S et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
8. 8. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ (1992) Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 89: 283-292
9. 9. Richter W, Shi Y, Baekkeskov S (1993) Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 90: 2832-2836
10. 10. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK (1994) Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 94: 2125-2129
11. 11. Schloot NC, Roep BO, Wegmann DR (1997) T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia 40: 332-338
12. 12. Karlsson MGE, Ludvigsson J (1998) Determination of mRNA expression for IFN-γ and IL-4 in lymphocytes from children with IDDM by RT-PCR technique. Diabetes Res Clin Pract 40: 21-30
13. 13. Karlsson MGE, Ludvigsson J (1998) Peptide from glutamic acid decarboxylase similar to coxsackie B virus stimulates IFN-γ mRNA expression in Th1-like lymphocytes from children with recent-onset insulin-dependent diabetes mellitus. Acta Diabetol 35: 137-144
14. 14. Jones DB, Crosby I (1996) Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia 39: 1318-1324
15. 15. Rudy G, Stone N, Harrison LC et al. (1995) Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1: 625-633
16. 16. Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M (1994) Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343: 1607-1608
17. 17. Sai P, Rivereau AS, Granier C, Haertlé T, Martignat L (1996) Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. Clin Exp Immunol 105: 330-337
18. 18. Karjalainen J, Martin JM, Knip M et al. (1992) A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 327: 302-307
19. 19. Martin JM, Trink B, Daneman D, Dosch H-M, Robinson B (1991) Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann Med 23: 447-452
20. 20. Karlsson MGE, Ludvigsson J (2000) The ABBOS-peptide from bovine serum albumin causes an IFN-γ and IL-4 mRNA response in lymphocytes from children with recent onset of type 1 diabetes. Diabetes Res Clin Pract 47: 199-207
21. 21. Gale EAM (1996) Molecular mechanisms of beta-cell destruction in IDDM: the role of nicotinamide. Horm Res 45: 40-43
22. 22. Cheung R, Karjalainen J, Vandermeulen J, Singal DP, Dosch H-M (1994) T cells from children with IDDM are sensitized to bovine serum albumin. Scand J Immunol 40: 623-628
23. 23. Worsaae A, Hejnaes K, Moody A et al. (1995) T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity 22: 183-189
24. 24. Hallewell RA, Masiarz FR, Najarian RC et al. (1985) Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library. Nucleic Acids Res 13: 2017-2034
25. 25. Arai N, Nomura D, Villaret D et al. (1989) Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 142: 274-282
26. 26. Gray PW, Goeddel DV (1982) Structure of the human immune interferon gene. Nature 298: 859-863
27. 27. Tang H, Matthes T, Carballido-Perrig N, Zubler RH, Kindler V (1993) Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: constitutive and inducible expression of interleukin-4 mRNA. Eur J Immunol 23: 899-903
28. 28. Czerkinsky C, Tarkowski A, Nilson L-Å (1984) Reverse enzyme-linked immunospot (RELISPOT) assay for detection of cells secreting immunoreactive substances. J Immunol Methods 72: 489-496
29. 29. Ekerfelt C, Ernerudh J, Bunikis J et al. (1997) Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: Secretion of IFN-γ predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol 79: 155-162
30. 30. Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet ii: 1279-1283
31. 31. Juhela S, Hyöty H, Hinkkanen A et al. (1999) T-cell responses to enterovirus antigens and to beta-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies. J Autoimmun 12: 269-278
32. 32. Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44: 652-657
33. 33. Palmer JP, Asplin CM, Clemons P et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339
34. 34. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75
35. 35. Rabinovitch A (1994) Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 43: 613-621
36. 36. Kallmann BA, Hüther M, Tubes M et al. (1997) Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 46: 237-243
37. 37. Espersen GT, Mathiesen O, Grunnet N, Jensen S, Ditzel J (1993) Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment. APMIS 101: 703-706
38. 38. Hussain MJ, Peakman M, Gallati H et al. (1996) Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39: 60-69
39. 39. Harrison LC, Honeyman MC, DeAizpurua HJ et al. (1993) Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365-1369
40. 40. Tian J, Atkinson MA, Clare-Salzler M et al. (1996) Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183: 1561-1567
41. 41. Lohmann T, Scherbaum WA (1996) T cell autoimmunity to glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. Horm Metab Res 28: 357-360
42. 42. Atkinson MA, Bowman MA, Kao KJ et al. (1993) Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 329: 1853-1858
43. 43. Vaarala O, Klemetti P, Savilahti E, Reijonen H, Ilonen J, Åkerblom HK (1996) Cellular immune response to cow's milk β-lactoglobulin in patients with newly diagnosed IDDM. Diabetes 45: 178-182
44. 44. Karounos DG, Bryson JS, Cohen DA (1997) Metabolically inactive insulin analog prevents type 1 diabetes in prediabetic NOD mice. J Clin Invest 100: 1344-1348
45. 45. Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler A-G (1998) Delay of Type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing insulin prophylaxis pilot trial. Diabetologia 41: 536-541
46. 46. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL (1995) Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β and prostaglandin-E. Am J Pathol 147: 1193-1199
47. 47. Romagnani S (1992) Human TH1 and TH2 subsets: Regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 98: 279-285
48. 48. Powrie F, Coffman RL (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 14: 270-274
49. 49. Fitch FW, McKisic MD, Lancki DW, Gajewski TF (1993) Differential regulation of murine T lymphocytes subsets. Annu Rev Immunol 11: 29-48
50. 50. Seder RA, Paul WE (1994) Acquisition of lymphokine-producing phenotype by CD4 + T cells. Annu Rev Immunol 12: 635-673
51. 51. Moore KV, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin 10. Annu Rev Immunol 11: 165-190